CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells

被引:679
作者
Yamaguchi, H [1 ]
Wang, HG [1 ]
机构
[1] Univ S Florida, Drug Discovery Program, H Lee Moffitt Canc Ctr & Res Inst, Dept Interdisciplinary Oncol,Coll Med, Tampa, FL 33612 USA
关键词
D O I
10.1074/jbc.M406933200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been shown that excess stress to the endoplasmic reticulum ( ER) triggers apoptosis, but the mechanisms underlying these processes remain unclear. We and others have reported previously that DR5 expression is up-regulated in thapsigargin (THG)-treated human cancer cells. Here, we provide evidence that CHOP is involved in THG up-regulation of DR5, which is a critical step for ER stress-induced apoptosis in human cancer cells. In human colon cancer HCT116 cells, knockdown of DR5 by siRNA blocked THG-induced Bax conformational change along with caspase-3 activation and cell death. Moreover, inhibition of CHOP expression attenuated DR5 up-regulation and apoptosis induced by THG, whereas ectopic expression of DR5 restored the sensitivity of CHOP siRNA-transfected cells to THG-induced apoptosis. In addition to HCT116 cells, inhibition of CHOP or DR5 induction also attenuated THG-induced cell death in other cancer cell lines including LNCaP, A2780S, and DU145, indicating that CHOP and DR5 are critical for ER stress-mediated apoptosis in human carcinoma cells. Furthermore, we identified a potential CHOP-binding site in the 5'-flanking region of the DR5 gene. Mutation of this site abrogated the enhanced reporter activity in response to THG treatment. Together, our findings suggest that CHOP regulates ER stress-induced apoptosis, at least in part, through enhancing DR5 expression in some types of human cancer cells.
引用
收藏
页码:45495 / 45502
页数:8
相关论文
共 33 条
[1]   Death receptors: Signaling and modulation [J].
Ashkenazi, A ;
Dixit, VM .
SCIENCE, 1998, 281 (5381) :1305-1308
[2]   Regulation of apoptosis by endoplasmic reticulum pathways [J].
Breckenridge, DG ;
Germain, M ;
Mathai, JP ;
Nguyen, M ;
Shore, GC .
ONCOGENE, 2003, 22 (53) :8608-8618
[3]   Proteases to die for [J].
Cryns, V ;
Yuan, JY .
GENES & DEVELOPMENT, 1998, 12 (11) :1551-1570
[4]   Cell death: Critical control points [J].
Danial, NN ;
Korsmeyer, SJ .
CELL, 2004, 116 (02) :205-219
[5]   TRAIL-induced apoptosis requires Bax-dependent mitochondria release of Smac/DIABLO [J].
Deng, YB ;
Lin, YH ;
Wu, XW .
GENES & DEVELOPMENT, 2002, 16 (01) :33-45
[6]   Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer [J].
Denmeade, SR ;
Jakobsen, CM ;
Janssen, S ;
Khan, SR ;
Garrett, ES ;
Lilja, H ;
Christensen, SB ;
Isaacs, JT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) :990-1000
[7]   Mammalian caspases: Structure, activation, substrates, and functions during apoptosis [J].
Earnshaw, WC ;
Martins, LM ;
Kaufmann, SH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :383-424
[8]   Organelle-specific initiation of cell death pathways [J].
Ferri, KF ;
Kroemer, G .
NATURE CELL BIOLOGY, 2001, 3 (11) :E255-E263
[9]   Transcriptional and translational control in the mammalian unfolded protein response [J].
Harding, HP ;
Calfon, M ;
Urano, F ;
Novoa, I ;
Ron, D .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2002, 18 :575-599
[10]   Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/TRAIL to induce apoptosis in Bax-proficient and -deficient cells [J].
He, Q ;
Huang, Y ;
Sheikh, MS .
ONCOGENE, 2004, 23 (14) :2554-2558